4Dmedical (Australia) Performance
| 4DX Stock | 0.46 0.01 2.22% |
The firm shows a Beta (market volatility) of 0.25, which signifies not very significant fluctuations relative to the market. As returns on the market increase, 4Dmedical's returns are expected to increase less than the market. However, during the bear market, the loss of holding 4Dmedical is expected to be smaller as well. At this point, 4Dmedical has a negative expected return of -0.51%. Please make sure to confirm 4Dmedical's semi deviation, coefficient of variation, jensen alpha, as well as the relationship between the downside deviation and information ratio , to decide if 4Dmedical performance from the past will be repeated at future time.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days 4Dmedical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
1 | 4DMedical Launches CTVQ, Eyeing Billion-Dollar Market - Nasdaq | 12/03/2024 |
| Begin Period Cash Flow | 69.6 M |
4Dmedical |
4Dmedical Relative Risk vs. Return Landscape
If you would invest 68.00 in 4Dmedical on September 30, 2024 and sell it today you would lose (22.00) from holding 4Dmedical or give up 32.35% of portfolio value over 90 days. 4Dmedical is producing return of less than zero assuming 4.404% volatility of returns over the 90 days investment horizon. Simply put, 39% of all stocks have less volatile historical return distribution than 4Dmedical, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
4Dmedical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for 4Dmedical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as 4Dmedical, and traders can use it to determine the average amount a 4Dmedical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1167
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 4DX |
Estimated Market Risk
| 4.4 actual daily | 39 61% of assets are more volatile |
Expected Return
| -0.51 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average 4Dmedical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of 4Dmedical by adding 4Dmedical to a well-diversified portfolio.
4Dmedical Fundamentals Growth
4Dmedical Stock prices reflect investors' perceptions of the future prospects and financial health of 4Dmedical, and 4Dmedical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on 4Dmedical Stock performance.
| Return On Equity | -0.51 | ||||
| Return On Asset | -0.27 | ||||
| Operating Margin | (7.55) % | ||||
| Current Valuation | 163.85 M | ||||
| Shares Outstanding | 411.6 M | ||||
| Price To Book | 2.67 X | ||||
| Price To Sales | 50.43 X | ||||
| Revenue | 3.75 M | ||||
| Gross Profit | 684.43 K | ||||
| EBITDA | (31.86 M) | ||||
| Net Income | (35.98 M) | ||||
| Total Debt | 5.12 M | ||||
| Book Value Per Share | 0.17 X | ||||
| Cash Flow From Operations | (30.87 M) | ||||
| Earnings Per Share | (0.10) X | ||||
| Total Asset | 120.02 M | ||||
| Retained Earnings | (152.04 M) | ||||
About 4Dmedical Performance
Assessing 4Dmedical's fundamental ratios provides investors with valuable insights into 4Dmedical's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the 4Dmedical is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
4Dmedical is entity of Australia. It is traded as Stock on AU exchange.Things to note about 4Dmedical performance evaluation
Checking the ongoing alerts about 4Dmedical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for 4Dmedical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| 4Dmedical generated a negative expected return over the last 90 days | |
| 4Dmedical has some characteristics of a very speculative penny stock | |
| 4Dmedical has high historical volatility and very poor performance | |
| The company reported the revenue of 3.75 M. Net Loss for the year was (35.98 M) with profit before overhead, payroll, taxes, and interest of 684.43 K. | |
| 4Dmedical generates negative cash flow from operations | |
| About 22.0% of the company shares are owned by insiders or employees | |
| Latest headline from news.google.com: 4DMedical Launches CTVQ, Eyeing Billion-Dollar Market - Nasdaq |
- Analyzing 4Dmedical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether 4Dmedical's stock is overvalued or undervalued compared to its peers.
- Examining 4Dmedical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating 4Dmedical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of 4Dmedical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of 4Dmedical's stock. These opinions can provide insight into 4Dmedical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for 4Dmedical Stock Analysis
When running 4Dmedical's price analysis, check to measure 4Dmedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 4Dmedical is operating at the current time. Most of 4Dmedical's value examination focuses on studying past and present price action to predict the probability of 4Dmedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 4Dmedical's price. Additionally, you may evaluate how the addition of 4Dmedical to your portfolios can decrease your overall portfolio volatility.